Debra Jennings | Head of Patient Services Operations, North America
Kyowa Kirin

Debra Jennings, Head of Patient Services Operations, North America, Kyowa Kirin

Debra Jennings is a transformational Healthcare Leader with 25 years of demonstrated success creating strategies to help elevate culture, patient centricity and business capabilities, predominantly within the pharmaceutical industry. “Deb’s” breadth of experience includes leadership roles in Marketing, Communications, Strategy and Operations, Data & Technology, Patient Services and Market Access. During her career, Deb has spent time with several organizations including Takeda, Express Scripts, Shire, Vertex Pharmaceuticals, and in her current role with Kyowa Kirin, Deb is the Head of North America Operations for Patient Services, where she works relentlessly to keep the patient at the center of all that is done. When she is not working Deb is actively involved with several business and affinity groups that support allyship. She is a founding member of the Patient Services Brain Trust. She is an alumnus of the Women Unlimited Program, a TEDx speaker, a member of Chief and has been part of the mentorship program with the Healthcare Businesswomen’s Association.  Deb founded the group WISE (Women’s Informational and Social Exchange) to empower career growth & advancement. She is an author and her book, “Leadership in Rough” is set to be published later in 2025. Deb received her bachelor’s degree in business from Eastern Nazarene College and is a Six Sigma Black Belt.

Appearances:



Day 1- World Orphan Drug Congress USA 2025 @ 12:35

Keynote: Navigating the intersection of technology and personalized care for Rare Disease patients

While AI and machine learning are revolutionizing healthcare, rare disease patients often need more personalized, one-on-one support. This panel brings together industry experts to delve into the nuanced balance between cutting-edge technology and compassionate, individualized care. Join us to explore how patient support programs can determine the right moments to employ advanced technological solutions and when to prioritize human interaction, ensuring the best outcomes for rare disease patients.

Sponsored by Eversana.

Day 2 - World Orphan Drug Congress USA 2025 @ 14:20

Panel: Navigating change: Evolving policy landscapes for rare disease access

last published: 24/Apr/25 11:35 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

Connect with us

 
 
 
 

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Kaylee Nguyen
kaylee.nguyen@terrapinn.com
 

 

 

 

Marketing & Press

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com